- Home
- EDSA vs PT Comparison
EDSA vs PT Comparison
Compare EDSA & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- PT
- Stock Information
- Founded
- EDSA 2015
- PT 2012
- Country
- EDSA Canada
- PT China
- Employees
- EDSA N/A
- PT N/A
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- PT Computer Software: Programming Data Processing
- Sector
- EDSA Health Care
- PT Technology
- Exchange
- EDSA Nasdaq
- PT Nasdaq
- Market Cap
- EDSA 13.8M
- PT 14.8M
- IPO Year
- EDSA N/A
- PT 2018
- Fundamental
- Price
- EDSA $4.24
- PT $0.94
- Analyst Decision
- EDSA Strong Buy
- PT
- Analyst Count
- EDSA 2
- PT 0
- Target Price
- EDSA $39.00
- PT N/A
- AVG Volume (30 Days)
- EDSA 10.2K
- PT 32.5K
- Earning Date
- EDSA 08-09-2024
- PT 04-30-2024
- Dividend Yield
- EDSA N/A
- PT N/A
- EPS Growth
- EDSA N/A
- PT N/A
- EPS
- EDSA N/A
- PT N/A
- Revenue
- EDSA N/A
- PT $7,434,458.00
- Revenue This Year
- EDSA N/A
- PT N/A
- Revenue Next Year
- EDSA N/A
- PT N/A
- P/E Ratio
- EDSA N/A
- PT N/A
- Revenue Growth
- EDSA N/A
- PT N/A
- 52 Week Low
- EDSA $2.46
- PT $0.71
- 52 Week High
- EDSA $8.33
- PT $1.38
- Technical
- Relative Strength Index (RSI)
- EDSA 43.73
- PT 41.46
- Support Level
- EDSA $4.20
- PT $0.76
- Resistance Level
- EDSA $5.00
- PT $1.12
- Average True Range (ATR)
- EDSA 0.23
- PT 0.10
- MACD
- EDSA -0.00
- PT -0.01
- Stochastic Oscillator
- EDSA 6.17
- PT 49.36
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About PT Pintec Technology Holdings Limited
Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.